Dr Reddy’s Shares Hit 52-Week High on Receiving VAI Status from USFDA
Shares of Dr Reddy’s Laboratories Ltd hit a 52-week high of Rs 6,388.45 on 12 February after USFDA (US Food and Drug Administration) cleared its...
Tag : US Food and Drug Administration (USFDA)
Piramal Pharma Shares Slump 5% as US Facility Receives 3 Observations
Shares of Piramal Pharma Ltd slumped 5% on 8 February after the company said that its Riverview facility in the US was under inspection by...
Aurobindo Pharma Shares Sink 5% as USFDA Issues 9 Observations
Shares of Aurobindo Pharma plummeted 5% on 5 February after the pharma major halted production at one unit after USFDA issued 9 observations for its...
Cipla Receives US FDA Letter Flagging Data Issues at MP Unit, Stock Emerges Top Nifty Losers
On November 23, 2023, Cipla, a prominent pharmaceutical company, witnessed a nearly 7% decline in its stock following the issuance of a warning letter by...
Aurobindo, Alembic Shares Slide as They Recalled Drugs from US Markets
Alembic Pharmaceuticals and Aurobindo Pharma issued voluntary recalls of different products in the US markets because of quality issues and manufacturing deficiencies, according to the...
Biocon Share Soars on USFDA’s ‘No Observations’ on Bengaluru Facility
On June 5, Biocon shares opened positively, gaining 1.5% as USFDA dispensed no observations on the company’s Bengaluru facility. Biotechnology company Biocon has logged that...
Sun Pharma Among Nifty’s Biggest Losers After USFDA Put Partial Clinical Trial on Deuruxolitinib Drug
Shares of Sun Pharmaceutical Industries fell more than 1% on May 2 after the US Food and Drug Administration (USFDA) suspended part of its clinical...
Piramal Pharma Shares Jump 10% as USFDA Ends Inspection of US Facility
Shares of Piramal Pharma soared nearly 10% in early trade on April 19 after the US Food and Drug Administration (USFDA) concluded an inspection of...
Zydus Lifesciences Share Hits 52-Week High on USFDA Approval for Osteoporosis Drug
Shares of Zydus Lifesciences hit a 52-week high in morning trade on April 19 after the company said it had received final approval from the...
Lupin Shares Slide as USFDA Issues 10 Observations on Pithampur Unit
Shares of Lupin fell in morning trade on March 31 after the US Food and Drug Administration issued Form 483 containing ten observations on the...
